Assignee
BAYER PHARMACEUTICALS CORP
US·68 granted patents·46 pending applications·1,143 citations·filing 1994–2014
Top patents by PatentIndex Score
114 records- 0197US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0296US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 0396US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0494US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0594US7041646B2Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted May 9, 2006·43 cites·3 claims
- 0694US6955807B1IL-2 selective agonists and antagonistsBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Oct 18, 2005·140 cites·10 claims
- 0794US6784157B2Peptides and peptidomimetics with structural similarity to human p53 that activate p53 functionBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·31 cites·6 claims
- 0892US6864069B2Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Mar 8, 2005·34 cites·3 claims
- 0992US6689353B1Stabilized interleukin 2BAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·73 cites·6 claims
- 1091US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 1191US6689582B1Polynucleotide molecules encoding proteins having proteinase inhibitor activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·39 cites·6 claims
- 1290US7244616B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Jul 17, 2007·15 cites·7 claims
- 1388US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 1488US6972319B1Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of useBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Dec 6, 2005·17 cites·5 claims
- 1587US6960601B2Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Nov 1, 2005·26 cites·8 claims
- 1687US6849638B24-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditionsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Feb 1, 2005·36 cites·12 claims
- 1786US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 1886US7511048B2PyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Mar 31, 2009·4 cites·10 claims
- 1986US7091228B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Aug 15, 2006·18 cites·20 claims
- 2086US6943172B2Rho-kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 13, 2005·20 cites·5 claims
- 2186US6903101B1Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Jun 7, 2005·21 cites·22 claims
- 2286US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 2386US6689883B1Substituted pyridines and pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Feb 10, 2004·20 cites·6 claims
- 2486US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 2585US7098207B2Imidazotriazinones and the use thereofBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Aug 29, 2006·7 cites·5 claims
- 2685US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 2783US7358386B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Apr 15, 2008·5 cites·2 claims
- 2883US6911449B2Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jun 28, 2005·7 cites·4 claims
- 2982US6828335B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·15 cites·102 claims
- 3081US7511041B2Fused azole-pyrimidine derivativesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Mar 31, 2009·22 cites·12 claims
- 3180US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 3280US6930114B2Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 16, 2005·19 cites·8 claims
- 3380US6924290B2Rho-kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Aug 2, 2005·14 cites·17 claims
- 3479US8772027B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2013·Granted Jul 8, 2014·1 cites·8 claims
- 3578US8765466B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2013·Granted Jul 1, 2014·1 cites·4 claims
- 3678US7951588B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2007·Granted May 31, 2011·1 cites·4 claims
- 3776US7112597B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 26, 2006·7 cites·73 claims
- 3876US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 3975US6994956B2Method for assaying enzyme activityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Feb 7, 2006·13 cites·24 claims
- 4074US7423156B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Sep 9, 2008·1 cites·20 claims
- 4174US6670175B2Cryopreservation bag assembly for mammalian cell linesBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 30, 2003·44 cites·6 claims
- 4272US6699860B2Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Mar 2, 2004·8 cites·20 claims
- 4371US6762184B2Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Jul 13, 2004·1 cites·4 claims
- 4470US9284591B2Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cellsBAYER PHARMACEUTICALS CORP·Filed 2014·Granted Mar 15, 2016·0 cites·12 claims
- 4570US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 4670US7144885B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Dec 5, 2006·4 cites·26 claims
- 4769US7803956B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Granted Sep 28, 2010·0 cites·19 claims
- 4867US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 4967US6780859B2Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Aug 24, 2004·3 cites·16 claims
- 5067US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BAYER PHARMACEUTICALS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →